Business Context and Reporting Period
Company: The Coca-Cola Company (KO)
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: September 26, 2025 (Third Quarter 2025)
Reporting Status: Large Accelerated Filer
The Company reported strong operational performance in Q3 2025, driven by favorable pricing initiatives and a significant reduction in "other operating charges" compared to the prior year. The period included the final milestone payment for the fairlife acquisition and continued divestiture activities in bottling operations.
Key Financial Metrics
| Metric (in millions) | Q3 2025 | Q3 2024 | 9M 2025 | 9M 2024 |
|---|---|---|---|---|
| Net Operating Revenues | $12,455 | $11,854 | $36,119 | $35,517 |
| Gross Profit | $7,658 | $7,190 | $22,445 | $21,806 |
| Operating Income | $3,982 | $2,510 | $11,921 | $7,283 |
| Net Income (Attributable to Shareowners) | $3,696 | $2,848 | $10,836 | $8,436 |
| Diluted EPS | $0.86 | $0.66 | $2.51 | $1.95 |
| Operating Cash Flow (9M) | $3,652 (2025) vs $2,854 (2024) | |||
| Free Cash Flow (9M) | $2,422 (2025) vs $1,593 (2024) | |||
| Total Debt (Long-term + Current) | $45,097 (Sep 26, 2025) | |||
| Cash & Equivalents | $12,732 (Sep 26, 2025) |
Margins (Q3 2025 vs Q3 2024):
- Gross Margin: 61.5% (up from 60.7%)
- Operating Margin: 32.0% (up from 21.2%)
Material Changes vs. Prior Period
- Revenue Growth: Net operating revenues increased 5% in Q3 and 2% for the nine months ended September 26, 2025. Growth was primarily driven by a 6% favorable impact from price, product, and geographic mix, offset by unfavorable foreign currency fluctuations (-3% for 9M) and flat volume growth.
- Operating Income Surge: Operating income increased 59% in Q3 and 64% for the nine months. This was largely due to a significant decrease in "Other Operating Charges" ($58M in Q3 2025 vs. $1,044M in Q3 2024), which included a $919M fairlife contingent consideration charge in the prior year.
- Divestitures: The Company recognized net gains of $331M from the sale of a portion of its interest in Coca-Cola Europacific Partners (CCEP) and $102M from refranchising bottling operations in India during the nine months ended September 26, 2025.
- Impairments: A $393M charge was recorded in Q3 2025 related to operations held for sale in Nigeria. Additionally, a $31M impairment charge was recorded for a trademark in Latin America.
Guidance, Outlook, and Risks
- Outlook: Management expects foreign currency exchange rate fluctuations to have an unfavorable impact on full-year 2025 net operating revenues and operating income. The Company projects an effective tax rate of approximately 20.7% for 2025, excluding the potential impact of significant nonoperating items.
- Capital Allocation: Priorities include investing in business operations, growing dividends, and repurchasing shares to offset dilution. The Company expects 2025 capital expenditures to be approximately $2.2 billion.
- IRS Tax Litigation: The Company is in ongoing litigation with the IRS regarding tax years 2007–2009. The Tax Court ruled against the Company, resulting in a $6.0 billion liability (including interest) which the Company paid in September 2024 as a deposit. The Company has appealed and believes it is more likely than not to prevail. However, if the Tax Court methodology is upheld for subsequent years (2010–2024), the potential aggregate incremental tax and interest liability could be approximately $12 billion.
- Future Impairment: The Company expects to record an impairment charge of approximately $1 billion in Q4 2025 related to bottling operations in Africa classified as held for sale.
- Legal Proceedings: A lawsuit filed by Los Angeles County regarding plastic packaging environmental impacts remains pending; the Company's motion to dismiss was denied in September 2025.
Investor Verification Checklist
- IRS Litigation Status: Monitor the appeal process in the U.S. Court of Appeals for the Eleventh Circuit and the potential $12 billion exposure if the Tax Court methodology is applied to future years.
- Q4 Impairment Charge: Verify the timing and magnitude of the expected $1 billion impairment charge related to African bottling operations.
- Foreign Currency Impact: Assess the sensitivity of future earnings to the strengthening U.S. dollar, which is projected to negatively impact full-year results.
- Divestiture Proceeds: Confirm the closing of the sale of bottling operations in Africa to Coca-Cola HBC AG (expected by end of 2026) and the associated cash flow impacts.
- Effective Tax Rate: Track the realization of the projected 20.7% effective tax rate, considering the discrete tax benefits from the IRS litigation deposit interest income.